|
|
||||||||
Journal of Lipid Research, Vol 20, 254-264, Copyright © 1979 by Lipid Research, Inc.
ARTICLES |
T Ishikawa and N Fidge
Changes in whole plasma and lipoprotien apoprotein concentrations were determined after a single injection of Triton WR 1339 into rats. Concentrations of apoproteins A-I (an activator of lecithin:cholesterol acyl transferase), arginine-rich apoprotein (ARP), and B apoprotein were measured by electroimmunoassay. The content of C-II apoprotein (an activaor of lipoprotein lipase) was estimated by the ability of plasma and lipoprotein fractions to promote hydrolysis of triglyceride in the presence of cow's milk lipase and also by isoelectric focusing on polyacrylamide gels. Apoproteins C-II and A-I were rapidly removed from high density lipoprotein (HDL) after Triton treatment and were recovered in the d 1.21 g/ml infranate fraction. A-I was then totally cleared from the plasma within 10--20 hr after injection. Arginine-rich apoprotein was removed from HDL and also partially cleared from the plasma. The rise in very low density lipoprotein (vldl) apoprotein that followed the removal of apoproteins from HDL was mostly antributed to the B apoprotein, although corresponding smaller increases were observed in VLDL ARP and C apoproteins. The triglyceride:cholesterol, triglyceride:protein, and B:C apoprotein ratios of VLDL more closely resembled nascent rather than plasma VLDL 10 hr after Triton injection. These studies suggest that the detergent may achieve its hyperlipidemic effct by disrupting HDL and thus removing the A-I and C-II proteins from a normal activating environment compirsing VLDL, HDL, and the enzymes. The possible involvement of intact HDL in VLDL catabolism is discussed in relation to other recent reports which also suggest that abnormalities of the VLDL-LDL system may be due to the absence of normal HDL.
This article has been cited by other articles:
![]() |
X. Huang, C. Yang, Y. Luo, C. Jin, F. Wang, and W. L. McKeehan FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet Induced Fatty Liver Diabetes, October 1, 2007; 56(10): 2501 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abe, S. Ikeda, T. Uchida, K. Yamashita, and T. Ichikawa Triton WR1339, an Inhibitor of Lipoprotein Lipase, Decreases Vitamin E Concentration in Some Tissues of Rats by Inhibiting Its Transport to Liver J. Nutr., February 1, 2007; 137(2): 345 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shibata, K.-i. Jishage, M. Arita, M. Watanabe, Y. Kawase, K. Nishikawa, Y. Natori, H. Inoue, H. Shimano, N. Yamada, et al. Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis FASEB J, December 1, 2006; 20(14): 2642 - 2644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Millar, D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339 J. Lipid Res., September 1, 2005; 46(9): 2023 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amigo, S. Zanlungo, J. F. Miquel, J. M. Glick, H. Hyogo, D. E. Cohen, A. Rigotti, and F. Nervi Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion J. Lipid Res., February 1, 2003; 44(2): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Chirieac, L. R. Chirieac, J. P. Corsetti, J. Cianci, C. E. Sparks, and J. D. Sparks Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1003 - E1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J.F. Tietge, A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B J. Lipid Res., November 1, 1999; 40(11): 2134 - 2139. [Abstract] [Full Text] |
||||
![]() |
B. Olson and B. O. Schneeman Alimentary Lipemia Is Enhanced in Fiber-Fed Rats J. Nutr., June 1, 1998; 128(6): 1031 - 1036. [Abstract] [Full Text] |
||||
![]() |
A.-M. Lefebvre, J. Peinado-Onsurbe, I. Leitersdorf, M. R. Briggs, J. R. Paterniti, J.-C. Fruchart, C. Fievet, J. Auwerx, and B. Staels Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1756 - 1764. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |